Saula Checquolo


Titolo Pubblicato in Anno
Loss of ATP2C1 function promotes trafficking and degradation of NOTCH1: Implications for Hailey-Hailey disease EXPERIMENTAL DERMATOLOGY 2023
pH-sensitive niosomes for ATRA delivery: A promising approach to inhibit Pin1 in high-grade serous ovarian cancer INTERNATIONAL JOURNAL OF PHARMACEUTICS 2023
Opsonin-deficient nucleoproteic corona Endows unPEGylated liposomes with stealth properties in vivo ACS NANO 2022
Human duodenal submucosal glands contain a defined stem/progenitor subpopulation with liver-specific regenerative potential journal of Hepatology 2022
5FU/Oxaliplatin-induced Jagged1 cleavage counteracts apoptosis induction in colorectal cancer: a novel mechanism of intrinsic drug resistance FRONTIERS IN ONCOLOGY 2022
Identification of a Novel Curcumin Derivative Influencing Notch Pathway and DNA Damage as a Potential Therapeutic Agent in T-ALL CANCERS 2022
Notch signaling in female cancers. A multifaceted node to overcome drug resistance CANCER DRUG RESISTANCE 2021
Notch3 contributes to T-cell leukemia growth via regulation of the unfolded protein response ONCOGENESIS 2020
Current trends in ATRA delivery for cancer therapy PHARMACEUTICS 2020
Mitogen-activated kinase kinase kinase 1 inhibits hedgehog signaling and medulloblastoma growth through GLI1 phosphorylation INTERNATIONAL JOURNAL OF ONCOLOGY 2019
Notch3 targeting. A novel weapon against ovarian cancer stem cells STEM CELLS INTERNATIONAL 2019
Histone Modifications Drive Aberrant Notch3 Expression/Activity and Growth in T-ALL FRONTIERS IN ONCOLOGY 2019
Notch signaling activation as a hallmark for triple-negative breast cancer subtype JOURNAL OF ONCOLOGY 2019
Wnt, notch, and TGF-β pathways impinge on hedgehog signaling complexity: an open window on cancer FRONTIERS IN GENETICS 2019
Kras/ADAM17-dependent Jag1-ICD reverse signalling sustains CRC progression and chemoresistance CANCER RESEARCH 2019
Molecular basis of Notch3-Pin1 functional crosstalk in aggressive female tumors: therapeutic targeting implications in ovarian cancer treatment PATHOBIOLOGY: FROM MOLECULAR DISEASE TO CLINICAL APPLICATION 2019
Notch3-Pin1 crosstalk in ovarian cancer: from molecular mechanism dissection to therapeutic application The XI Notch meeting 2019
Getting insights into Pin1-Notch3 functional crosstalk in ovarian cancer NEW TECHNOLOGIES TO FIGHT CANCER 2019
PLK1 targets NOTCH1 during DNA damage and mitotic progression THE JOURNAL OF BIOLOGICAL CHEMISTRY 2019
Notch3 contributes to T-cell leukemia growth via regulation of the unfolding protein response The Biennial Congress of the Italian Association of cell biology and differentiation 2019

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma